This site is intended for healthcare professionals outside the U.S.
OTEZLA is the only oral intracellular PDE4 inhibitor that modulates a network of cytokines implicated in PsA1
Reference: 1. Coates LC, Kavanaugh A, Mease PJ, et al. Group for research and assessment of psoriasis and psoriatic arthritis 2015 treatment recommendations for psoriatic arthritis. Arthritis Rheumatol. 2016;68(5):1060-1071.
Please choose a country